ZetrOZ Systems revolutionizes sustained acoustic medicine

0

TRUMBULL, Conn., Oct. 17, 2022 (GLOBE NEWSWIRE) — ZetrOZ Systems, creator and manufacturer of the sam® portable ultrasound device product line, is rapidly revolutionizing supported acoustic medicine therapies with the introduction of its latest innovation, the sam® x1. The sam®x1 provides effective, high quality soft tissue and wound healing capabilities at home. A video of the device’s performance and features is available here.

“We intentionally and wisely designed the sam®x1 with ergonomics in mind to deliver the same soft tissue healing for pain and injury in cordless form,” said Dr. George Lewis, Founder and CEO. from ZetrOZ Systems. “The sam®x1 is poised to make a difference in the lives of hundreds of thousands of patients with soft tissue injuries.”

Designed for ergonomics and delivering ultrasound to increase circulation and promote soft tissue healing, sam®x1 delivers 33 times more energy than a bone growth stimulator after just one hour of treatment. Further research shows:

  • Medical staff are 87% satisfied and have more confidence in sam® to speed up the healing process of overuse injuries (Draper et al., 2021)
  • The sam® treatment ensures tissue healing and recovery, improves patient function and reduces pain. When patients were unresponsive to physical therapy, sam® was found to be a useful adjunct to facilitate recovery and return to work (Winkler et al., 2021)
  • sam® led to clinical improvement in the patient within two weeks of treatment and a 50% reduction in pain medication (Walters et al., 2022, clinical presentation)
  • 87.3% of athletes are highly responsive to treatment and have a high level of confidence for improved function and return to work after 30 days of sam® use (Walters et al., 2022, clinical presentation)

For the treatment of acute and chronic musculoskeletal conditions, sam®x1 is an effective tool for decreasing pain, increasing movement and blood circulation and improving quality of life.

The sam® gel capture patch creates the ideal connection and adapts to healing. Cordless capability allows sam® to attach securely and discreetly, balancing the weight but allowing patients to participate in aggressive activities. A sturdy storage case, including two rapid chargers, quick start guide and user manual, allows for on-the-go use.

“Backed by thousands of positive patient outcomes, sam®x1 is changing the paradigm in the treatment of soft tissue injuries, and we are thrilled to see doctors and physicians using this treatment to improve the lives of their patients,” concluded Dr. Lewis.

After more than a decade of development, sam®x1 is the first long-lasting cordless ultrasound system cleared by the FDA for home prescription use. sam®x1 is made in the USA and covered by 48 patents.

To learn more, visit zetrozsystems.com.

About ZetrOZ Systems
ZetrOZ Systems is at the forefront of sports medicine therapeutic innovation, developing wearable bioelectronic devices for the delivery of Sustained Acoustic Medicine (sam®). Federally researched and funded, ZetrOZ is built on proprietary medical technology with +46 patents and is the exclusive manufacturer and developer of sam®, a line of products designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.

Contact information:
Kayar nozzle
[email protected]

Related Images

Image 1: sam® x1 cordless soft tissue healing treatment

cordless sam® x1 soft tissue healing treatment

This content was posted through the press release distribution service on Newswire.com.

  • sam® Cordless Soft Tissue Healing Treatment x1

Share.

About Author

Comments are closed.